Latest News

 Filter by Provider

Two different tools for two different jobs.

Cimpress (NASDAQ:CMPR) used its 2026 Investor Day to outline a strategy centered on higher-value customers, expanded offerings in “elevated products,” manufacturing and supply-chain efficiency, shared technology platforms and artificial intelligence. Founder, Chairman and CEO Robert Keane said the

This ETF's impressive track record has built immense for long-term investors.

There's more than just a cost-of-living adjustment in store for Social Security recipients.

The software giant split its shares nine times over its first 17 years as a public company. Is a 10th split on the way?

These stocks should hold up well no matter what the future holds for the overall market.

Soaring long-duration Treasury bond yields are sending an unmistakable message to President Trump, Wall Street, and investors.

The chip stock has more than tripled this year. Can it actually do it again?

Rogers (NYSE:ROG) outlined a plan to grow annual sales to more than $1.5 billion by 2030, supported by expansion in its core markets and targeted opportunities in AI data centers, battery systems and electromagnetic interference, or EMI, shielding. At the company’s 2026 Analyst and Investor Day, Pr

This Canadian dividend stock has a great combination of a 5.8% dividend yield, resilient cash flow, and billions of dollars in growth projects makes it a compelling long-term income stock.

CrowdStrike and Palo Alto are positioned for long-term growth.

Bristol Myers Squibb isn't a growth stock, but it may offer something to bargain hunters and dividend seekers.

Amylyx Pharmaceuticals (NASDAQ:AMLX) said its Phase III trial of avexitide in post-bariatric hypoglycemia, or PBH, met its primary endpoint and all secondary endpoints, positioning the company to submit a New Drug Application to the U.S. Food and Drug Administration before year-end. PBH is a chroni

Want to make sure you're on track for retirement? See how your savings stands up to your peers.

This stock has a much cheaper valuation than the two large-cap space giants.

Paramount Gold Nevada (NYSEAMERICAN:PZG) said it expects to receive final state permits for its Grassy Mountain gold project in Oregon before the end of the calendar year, a milestone that the company said would support the development of what could become Oregon’s first permitted mine under the sta

The social media giant is unlikely to repeat last month's gains this month.

Nike is working to rebuild relationships with wholesalers.

Management is forecasting 5% revenue growth this year.

Management is doing the best it can, given the challenges it faces.

I have been bullish on this stock for several years.

Driverless car companies and the decisions they make will be critical for Uber stock investors.

Several giant companies are rooting for Anthropic's success.

The remarkable results are far better than anything I've ever seen before.

These growth stocks offer direct exposure to the AI data center build-out.

These two coins are heavily dependent on the success of Robinhood's new blockchain, but that's going swimmingly for them so far.

Sandisk now has the second-highest nominal stock price among tech stocks.

Digi International (NASDAQ:DGII) said it has agreed to acquire Oslo, Norway-based wireless sensing company Disruptive Technologies, a transaction the company expects to close following regulatory approval before the end of calendar 2026. Chief Executive Officer Ron Konezny said Disruptive Technolog

Salesforce commands a 7-to-1 revenue advantage, yet CrowdStrike has posted uninterrupted quarter-over-quarter growth while Salesforce stumbled occasionally.

NVIDIA boasts a 55.6% net margin and $96.7 billion in free cash flow, while SK Hynix trades at a fraction of the valuation despite 44.2% profitability.

If the typical stock trailed, which stocks carried the index?

Big Sky Industrial Inc. Common Stock (NASDAQ:BSIN) outlined plans to begin commercial helium sales from its Montana-based Phase 1 project in the first quarter of 2027, with construction underway and a remaining EPA sequestration permit among the key milestones before startup. Speaking at Noble Capi

Bloom Energy has been caught up in the AI spending spree, but have investors pushed the stock too far?

Chip stocks jumped on the Muse rollout.

Ultrapar Participacoes (NYSE:UGP) outlined its capital-allocation priorities, operating initiatives and portfolio strategy at its Ultra Day event, with executives emphasizing safety, financial discipline and investments in logistics, energy distribution and adjacent businesses. Chief Executive Offi

Agnico Eagle shares had a rough week, but record cash flow and a net-cash balance sheet keep the thesis interesting.

If you are looking for a reliable income stream, these two Dividend Kings should be on your watch list, if not your buy list.

Fortis is a dividend stock I'd hold through a downturn. Its regulated utilities and dividend growth support a patient approach to investing.

TC Energy (TSX:TRP) is an undervalued dividend titan to buy as shares come in further.

Adicet Bio (NASDAQ:ACET) reported positive clinical data for prula-cel, its investigational allogeneic gamma delta CAR-T cell therapy, in patients with systemic lupus erythematosus, or SLE, including patients with lupus nephritis. The company said that, among evaluable lupus nephritis patients, 50%

Before adding money to your TFSA, make sure you know your actual contribution room.

These two Canadian dividend stocks offer a great mix of essential businesses, regular dividends, and long-term growth investments that could make them appealing retirement holdings for years to come.